Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.23
-0.03 (-0.30%)
Apr 2, 2026, 3:20 PM EDT - Market open
Grifols Revenue
In the year 2025, Grifols had annual revenue of 7.52B EUR with 4.33% growth. Grifols had revenue of 1.98B in the quarter ending December 31, 2025, with 0.32% growth.
Revenue (ttm)
7.52B EUR
Revenue Growth
+4.33%
P/S Ratio
0.75
Revenue / Employee
316,974 EUR
Employees
23,737
Market Cap
6.61B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.52B | 312.00M | 4.33% |
| Dec 31, 2024 | 7.21B | 620.00M | 9.41% |
| Dec 31, 2023 | 6.59B | 528.03M | 8.71% |
| Jan 1, 2023 | 6.06B | 1.13B | 22.92% |
| Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pfizer | 62.58B |
| Novartis AG | 56.67B |
| Sanofi | 54.85B |
| Novo Nordisk | 48.59B |
| Bristol-Myers Squibb Company | 48.19B |
| GSK plc | 43.97B |
| Amgen | 36.75B |
| Gilead Sciences | 29.44B |
GRFS News
- 2 days ago - Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates - GlobeNewsWire
- 8 days ago - Grifols (GRFS) Considers U.S. IPO Amid Strategic Shift - GuruFocus
- 8 days ago - Grifols (GRFS) Plans U.S. IPO for Biopharma Business - GuruFocus
- 8 days ago - Grifols Plans IPO of U.S. Biopharma Business - The Wall Street Journal
- 8 days ago - Grifols (GRFS) Considers US IPO for Biopharma Unit - GuruFocus
- 8 days ago - Grifols (GRFS) Contemplates U.S. Biopharma Unit IPO - GuruFocus
- 8 days ago - Grifols approves IPO of its US biopharma business - Reuters
- 16 days ago - Grifols (GRFS) Reveals Advancements in Early Parkinson's Detection - GuruFocus